Researchers from Simon Fraser University have unveiled an artificial intelligence framework that could transform drug development and accelerate the discovery of new medicines.

Researchers have introduced DiffSMol, a generative AI model capable of generating realistic 3D structures of small molecules that can serve as promising drug candidates.

The hybrid microscope can be useful for studying proteins, as they change their 3D orientation in response to their environment to interact with other molecules and perform their functions.

For the study, the researchers used a type of technology called spatial omics and combined this with deep learning to produce 3D datasets to unveil the brain’s myriad of characteristics down to the ...